References

Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of global burden of disease study 2019

10.1186/s12916-023-02925-4 · 2023 · External reference

The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990–2019

10.1186/s12889-024-18445-6 · 2024 · External reference

World health organization 2020 guidelines on physical activity and sedentary behaviour

10.1136/bjsports-2020-102955 · 2020 · External reference

Oxidative stress in atherosclerosis

10.1007/s11883-017-0678-6 · 2017 · External reference

Mechanisms of oxidized LDL-Mediated endothelial dysfunction and its consequences for the development of atherosclerosis

10.3389/fcvm.2022.925923 · 2022 · External reference

Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American heart association

10.1161/cir.0000000000001078 · 2022 · External reference

Personal-level protective actions against particulate matter air pollution exposure: a scientific statement from the American heart association

10.1161/cir.0000000000000931 · 2020 · External reference

Guidance to reduce the cardiovascular burden of ambient air pollutants: a policy statement from the American heart association

10.1161/cir.0000000000000930 · 2020 · External reference

Adverse childhood experiences and cardiovascular risk among young adults: findings from the 2019 behavioral risk factor surveillance system

10.3390/ijerph191811710 · 2022 · External reference

Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American heart association

10.1161/cir.0000000000000444 · 2016 · External reference

American society for preventive cardiology 2024 cardiovascular disease prevention: highlights and key sessions

2024 · External reference

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline for the management of dyslipidemia

2026 · External reference

2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias

10.1093/eurheartj/ehaf190 · 2025 · External reference

2021 ESC guidelines on cardiovascular disease prevention in clinical practice

10.1093/eurheartj/ehab484 · 2021 · External reference

Managing atherosclerotic cardiovascular risk in young adults

10.1016/j.jacc.2021.12.016 · 2022 · External reference

Epidemiology of cardiovascular disease in young individuals

10.1038/nrcardio.2017.154 · 2018 · External reference

Cardiovascular risk factors in young adults

10.1097/jcn.0000000000000150 · 2015 · External reference

Effect of air pollution on the global burden of cardiovascular diseases and forecasting future trends of the related metrics: a systematic analysis from the global burden of disease study 2021

10.3389/fmed.2024.1472996 · 2024 · External reference

Endothelial cell dysfunction and the pathobiology of atherosclerosis

10.1161/circresaha.115.306301 · 2016 · External reference

Electronic cigarette exposure causes vascular endothelial dysfunction due to NADPH oxidase activation and eNOS uncoupling

10.1152/ajpheart.00460.2021 · 2022 · External reference

Cardiovascular risk of electronic cigarettes: a review of preclinical and clinical studies

10.1093/cvr/cvz256 · 2019 · External reference

Impact of objectively-measured sleep duration on cardiometabolic health: a systematic review of recent evidence

10.3389/fendo.2022.1064969 · 2022 · External reference

Air pollution and cardiovascular disease: a systematic review of the effects of air pollution, including bushfire smoke, on cardiovascular disease

2025 · External reference

Stress and cardiovascular disease: an update

10.1038/s41569-024-01024-y · 2024 · External reference

Metabolic syndrome

10.1038/s41572-024-00563-5 · 2024 · External reference

2018 AHA/ACC guideline on the management of blood cholesterol

2019 · External reference

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis society consensus statement

10.1093/eurheartj/ehac361 · 2022 · External reference

Primary prevention of subclinical atherosclerosis in young adults: JACC review topic of the week

10.1016/j.jacc.2023.09.817 · 2023 · External reference

Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults

10.1093/eurjpc/zwae039 · 2024 · External reference

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease

2019 · External reference

Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: a pragmatic randomized clinical trial

10.1016/j.atherosclerosis.2020.12.020 · 2021 · External reference

Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial

10.33963/kp.a2021.0112 · 2021 · External reference

The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial

10.33963/kp.a2021.0108 · 2021 · External reference

Digital health interventions in patient management following acute coronary syndrome: a meta-analysis of the literature

10.14744/anatoljcardiol.2022.2254 · 2023 · External reference

The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial

10.1080/00015385.2023.2223005 · 2023 · External reference

Telemedicine for healthcare: capabilities, features, barriers, and applications

2021 · External reference